Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00607867 · ClinicalTrials.gov registry record · NA
LoBAG30 Diet in Patients on Metformin
A NA study, sponsored by US Department of Veterans Affairs.
- Terminated
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT00607867 is a NA study that was terminated before completion, run by US Department of Veterans Affairs. The registered enrollment target is 20 participants.
The verdict
NCT00607867, a NA study, was terminated before completion, sponsored by US Department of Veterans Affairs.
- TERMINATED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
We will determine the metabolic response to a Low Biologically Available Glucose Diet (LoBAG30) in subjects currently receiving the maximum dose of metformin as monotherapy in whom the glycohemoglobin is not at an acceptable level (\>8.0%). Our hypothesis is that introduction of a LoBAG30 diet to subjects currently treated with a full therapeutic dose of metformin will improve blood glucose control in people who have not achieved an acceptable total glycohemoglobin on metformin alone.
Interventions
- OTHER Control Diet
- OTHER LoBAG30 diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2008-04 |
| Est. Completion | 2011-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00607867
The ClinicalTrials.gov registry entry for NCT00607867 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control Diet is the first listed.
NCT00607867 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00607867 about?
NCT00607867 is a clinical study titled "LoBAG30 Diet in Patients on Metformin". We will determine the metabolic response to a Low Biologically Available Glucose Diet (LoBAG30) in subjects currently receiving the maximum dose of metformin as monotherapy in whom the glycohemoglobin is not at an acceptable level (\>8.0%). Our hypothesis is that introduction of a LoBAG30 diet to su...
What is the current status of trial NCT00607867?
This trial is currently terminated. It is a NA study. The enrollment target is 20 participants. The study started on 2008-04. Estimated completion is 2011-03.
What interventions are being tested in trial NCT00607867?
The interventions under investigation include: Control Diet (OTHER), LoBAG30 diet (OTHER).
Who is sponsoring clinical trial NCT00607867?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.